Capstone Holding

Capstone Holding Current Liabilities

The Current Liabilities of Capstone Holding (CAPS) as of Oct 27, 2026 is 22.92 M USD. In the previous year, Current Liabilities was 12.55 M USD — a change of 82.66% (higher).

Current Liabilities

22.92 MUSD

YoY

82.66%

Last updated:

Current Liabilities of Capstone Holding is 2025 22.92 M USD. Current Liabilities of Capstone Holding was 2024 12.55 M USD. It decreases by 82.66% higher compared to the previous year.

The Capstone Holding Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
247,000.00 USD
Jan 1, 2019
1.17 M USD
Jan 1, 2020
11.04 M USD
Jan 1, 2021
9.18 M USD
Jan 1, 2022
14.61 M USD
Jan 1, 2023
15.97 M USD
Jan 1, 2024
12.55 M USD
Jan 1, 2025
22.92 M USD
The Capstone Holding Current Liabilities history
YEARCurrent LiabilitiesYoY
22.92 MUSD+82.66%
12.55 MUSD-21.42%
15.97 MUSD+9.29%
14.61 MUSD+59.23%
9.18 MUSD-16.84%
11.04 MUSD+847.38%
1.17 MUSD+371.66%
247,000.00USD-89.92%
2.45 MUSD+80.28%
1.36 MUSD+7.18%
1.27 MUSD+188.18%
440,000.00USD+340.00%
100,000.00USD-74.62%
394,000.00USD+231.09%
119,000.00USD-95.62%
2.72 MUSD-33.87%
4.11 MUSD+42.01%
2.89 MUSD-29.48%
4.10 MUSD-21.75%
5.24 MUSD-22.72%
6.78 MUSD-5.84%
7.20 MUSD+28.01%
5.63 MUSD-37.72%
9.04 MUSD-24.80%
12.01 MUSD-19.89%
15.00 MUSD+72.38%
8.70 MUSD-23.01%
11.30 MUSD-32.74%
16.80 MUSD+57.01%
10.70 MUSD+245.16%
3.10 MUSD+106.67%
1.50 MUSD+114.29%
700,000.00USD0.00%
700,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Capstone Holding Stock analysis

What does Capstone Holding do? Capstone Therapeutics Corp. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for unmet medical needs. The company was founded in 1987 and is headquartered in Tempe, Arizona. It began as a research project at Arizona State University, eventually leading to the founding of the company. Capstone Therapeutics utilizes its technology platform in peptide chemistry, cell biology, and pharmacology to develop therapies for diseases with limited treatment options. Its core business includes developing medications for neurodegenerative diseases like Alzheimer's and oncological diseases with no effective treatment options. The company collaborates with other industry leaders in biotechnology and holds a strong intellectual property position. Capstone Therapeutics aims to improve the lives of individuals with serious illnesses through its innovative products and strategic approach. Capstone Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Capstone Holding stock

Current Liabilities of Capstone Holding is 22.92 M USD in 2025.

Current Liabilities of Capstone Holding changed from 12.55 M USD to 22.92 M USD, representing a 82.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Capstone Holding since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Capstone Holding historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Capstone Holding

All Key Metrics — Capstone Holding